Stimuli-sensitive drug carriers can aid in the treatment of diabetes as glucose biosensors and glucose-triggered insulin delivery systems.
Stimuli-sensitive drug carriers can aid in the treatment of diabetes as glucose biosensors and glucose-triggered insulin delivery systems.
Researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise.
American researchers report new coating to improve promising treatment for Type 1 diabetes.
New technology could make diabetes management more accessible to those who need it most.
Young Innovator Awardee for 2025, Komor leads a group at UCSD developing precision genome editing methods using chemical biology.
A new study identified the potential pathway responsible for linking high hemoglobin to polycystic ovary syndrome.
Cells that can no longer divide may play a role in the chronic inflammation that weakens the immune system and contributes to aging.
This safer, non-surgical treatment for diabetic limb ischemia could help patients with severe blood flow complications.
The protein helps convert white fat tissue into calorie-burning beige fat, providing a potential target for weight loss and obesity treatments.
Microneedles allow scientists to precisely control the delivery of drugs to chronic wound sites and restore natural healing processes.